老年急性髓系白血病患者接受强化与非强化化疗的生活质量与情绪
研究纳入100例新诊断老年AML患者,分别在强化或非强化化疗组各50例,纵向评估生活质量和心理困扰。患者生活质量随时间改善,焦虑症状随时间减轻,抑郁症状无变化;强化与非强化化疗组在各时间点的生活质量、抑郁和焦虑均无显著差异。
要点
- 老年AML患者治疗期间生活质量与焦虑症状随时间改善。
- 强化与非强化化疗组的生活质量和情绪轨迹相似。
- 基线时临床显著抑郁和焦虑症状分别占33.3%和30.0%。
核心结论
- 老年AML患者在接受治疗期间生活质量和焦虑症状改善,强化与非强化化疗患者的生活质量和情绪轨迹相似。
研究设计与样本
- 纵向研究,纳入100例新诊断老年AML患者(≥60岁),强化化疗组50例接受阿糖胞苷联合蒽环类药物,非强化化疗组50例接受去甲基化药物。
- 在基线及诊断后2、4、8、12和24周评估生活质量(癌症治疗功能评估-白血病量表)和心理困扰(医院焦虑抑郁量表)。
- 符合条件患者入组率为75.2%(100/133),在开始化疗后72小时内入组。
主要发现
- 患者生活质量随时间改善(β=0.32,P=0.013)。
- 基线时33.3%(33/100)和30.0%(30/100)的患者分别报告临床显著抑郁和焦虑症状,组间无差异。
- 抑郁症状随时间无变化,焦虑症状随时间减轻(β=-0.08,P<0.001)。
- 强化与非强化化疗组在任何时间点的生活质量、抑郁和焦虑症状均无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Older patients with AML face difficult treatment decisions as they can be treated either with 'intensive' chemotherapy requiring prolonged hospitalization, or 'non-intensive' chemotherapy. Although clinicians often perceive intensive chemotherapy as more burdensome, research is lacking on patients' quality of life (QOL) and psychological distress. We conducted a longitudinal study of older patients (≥60 years) newly diagnosed with AML receiving intensive (cytarabine/anthracycline combination) or non-intensive (hypomethylating agents) chemotherapy. We assessed patients' QOL [Functional-Assessment-of-Cancer-Therapy-Leukemia] and psychological distress [Hospital-Anxiety-and-Depression-Scale] at baseline and 2, 4, 8, 12, and 24 weeks after diagnosis. We enrolled 75.2% (100/133) of eligible patients within 72-hours of initiating intensive (n = 50) or non-intensive (n = 50) chemotherapy. Patient QOL improved over time (β = 0.32, P = 0.013). At baseline, 33.3% (33/100) and 30.0% (30/100) of patients reported clinically significant depression and anxiety symptoms, respectively, with no differences between groups. Patients' depression symptoms did not change over time, while their anxiety symptoms decreased over time (β = -0.08, P < 0.001). Patient-reported QOL, depression and anxiety symptoms did not differ significantly at any time point between those who received intensive versus non-intensive chemotherapy. Older patients with AML experience improvements in their QOL and anxiety while undergoing treatment. Patients receiving intensive and non-intensive chemotherapy have similar QOL and mood trajectories.
引用
- El-Jawahri A, Abel GA, Traeger L, et al. Quality of life and mood of older patients with acute myeloid leukemia (AML) receiving intensive and non-intensive chemotherapy. Leukemia. 2019. PMID: 30923318. doi:10.1038/s41375-019-0449-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。